Efficacy of lapatinib monotherapy on occult breast cancer
$ 16.99 · 4.7 (408) · In stock
PRIMARY THERAPY OF EARLY BREAST CANCER 12th - Oncoletter
Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection: Joint report of the Intractable Liver Disease Study Group of Japan and the Japanese Study Group of the Standard Antiviral
PDF) A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer
研究業績 - 東京女子医科大学 乳腺外科
Histopathological observations of a skin biopsy (human epidermal growth
20745 PDFs Review articles in ERYTHEMA
Eiichiro NOGUCHI, Tokyo Women's Medical University, Tokyo, Department of Surgery II
Frontiers Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer
Abstract Breast Cancer Research and Treatment
Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases. - Abstract - Europe PMC
When Standard Therapy Fails in Breast Cancer: Current and Future
Circulating Biomarkers in Breast Cancer - ScienceDirect
20745 PDFs Review articles in ERYTHEMA
Full article: Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?
Breast cancer Nature Reviews Disease Primers